C Aspa Scorb was formulated as a mineral transporter based on results of studies by HansNieper MD of West Germany. A seven year study concluded that a 50/50 mixture of potassium, magnesium and aspartates decreased the death rate from myocardial infarct by 84 percent. Further independent clinical studies in Australia confirmed these results.

It is well known that a high potency intake of mineral ascorbates increases urinary excretion of several minerals, chiefly calcium and magnesium. The ascorbate bonding of calcium is of prime importance for the removal of unwanted mineral deposits. Additional minerals have been added to C Aspa Scorb to insure that proper mineral levels are maintained. Ascorbated minerals are partially bound and partially electrostatically associated which assures their availability.

Summary of pharmacological actions:

• Research indicates that vitamin C helps to prevent blood clots
• Studies show that patients given two grams of vitamin C daily had fewer adhesive platelets.
• Further studies reveal that treatment with vitamin C will lower LDL (bad cholesterol) and increase HDL (good cholesterol), concentration and also stimulate the production of the enzyme LPL (lipotrophic lipase) which acts as a cleaning agent on the vascular walls.
• In other tests with patients suffering from heart disease, vitamin C was found to increase fibrinolytic activity by over 60%, even though none of the patients was deficient in vitamin C.

Special note:
C Aspa Scorb can be used wherever a potent vitamin C product is required and can be tailored to just about any potency needed.